{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:45:16Z","timestamp":1790419516646,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJEM"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec id=\"S1481803519004901_sec_a1\" sec-type=\"other\"><jats:title>Objective<\/jats:title><jats:p>Acutely painful osteoporotic vertebral compression fractures are associated with hospitalization and mortality in older adults. Calcitonin may be an alternative to opioid or nonopioid analgesia for treating acute compression fracture pain in emergency and primary care settings. This review summarizes pain, function, and adverse events associated with calcitonin.<\/jats:p><\/jats:sec><jats:sec id=\"S1481803519004901_sec_a2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>We searched MEDLINE, EMBASE, The Cochrane Library, clinical trials registries, and reference lists of included studies. Eligible studies evaluated the effect of synthetic calcitonins (salmon, eel, and human) on pain scores in adults \u226560 years old with a recent atraumatic compression fracture. Two reviewers screened studies, extracted data, and allocated bias in duplicate. A random effects meta-analysis evaluated standard mean difference (SMD) and heterogeneity (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>).<\/jats:p><\/jats:sec><jats:sec id=\"S1481803519004901_sec_a3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>Of 1,198 articles screened, 11 were included (9 in the meta-analysis). Treatment lasted from 14 days to 6 months. Pain was lower in the salmon calcitonin group (100\u2013200 IU IM or NAS, daily) than the control group with high certainty of evidence at week 1 (SMD, -1.54; 95% confidence interval [CI], -2.02 \u2013 -1.06; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 52%), representing a number needed to treat of two. The analgesic efficacy of salmon calcitonin at 4 weeks was unclear due to substantial heterogeneity. There was low certainty evidence that calcitonin did not increase the overall risk of adverse events, including nausea and vomiting (risk ratio, 2.10; 95% CI, 0.87\u20135.08; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 47%).<\/jats:p><\/jats:sec><jats:sec id=\"S1481803519004901_sec_a4\" sec-type=\"conclusions\"><jats:title>Conclusions<\/jats:title><jats:p>Calcitonin is beneficial and appears safe for treating acute pain associated with compression fractures. Further studies may improve the certainty of evidence.<\/jats:p><\/jats:sec>","DOI":"10.1017\/cem.2019.490","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T06:19:48Z","timestamp":1584598788000},"page":"359-367","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy of calcitonin for treating acute pain associated with osteoporotic vertebral compression fracture: an updated systematic review"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9854-3462","authenticated-orcid":false,"given":"Emily","family":"Boucher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Rosgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"S1481803519004901_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.09.014"},{"key":"S1481803519004901_ref29","first-page":"205","article-title":"Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures","volume":"11","author":"Pun","year":"1989","journal-title":"Clin Ther"},{"key":"S1481803519004901_ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1744806917720316"},{"key":"S1481803519004901_ref7","first-page":"653","article-title":"Dangers of NSAIDs in the elderly","volume":"35","author":"Smith","year":"1989","journal-title":"Can Fam Physician"},{"key":"S1481803519004901_ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1103053"},{"key":"S1481803519004901_ref28","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-199912000-00004"},{"key":"S1481803519004901_ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0159-0"},{"key":"S1481803519004901_ref27","doi-asserted-by":"publisher","DOI":"10.1080\/17453674.1997.11744761"},{"key":"S1481803519004901_ref37","unstructured":"Health Canada. Important Changes to the Availability and Conditions of Use for Drugs Containing Calcitonin. 2013. Available at: https:\/\/healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2013\/34843a-eng.php (accessed December 27, 2019)."},{"key":"S1481803519004901_ref9","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.100771"},{"key":"S1481803519004901_ref16","unstructured":"Rohatji, A. WebPlotDigitizer 2019 Available at: https:\/\/automeris.io\/WebPlotDigitizer (accessed December 27, 2019)."},{"key":"S1481803519004901_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jos.2016.12.021"},{"key":"S1481803519004901_ref20","unstructured":"Sch\u00fcnemann, H , Bro\u017cek, J , Guyatt, G , Oxman, A , eds. GRADE handbook for grading quality of evidence and strength of recommendations. Available at: guidelinedevelopment.org\/handbook (accessed December 27, 2019)."},{"key":"S1481803519004901_ref1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2018.59.2.317"},{"key":"S1481803519004901_ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1798-8"},{"key":"S1481803519004901_ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3631-6"},{"key":"S1481803519004901_ref30","first-page":"1039","article-title":"Calcitonin in acute pain due to vertebral fracture in osteoporosis. Cooperative study. [Spanish]","volume":"115","author":"Arinoviche","year":"1987","journal-title":"Rev Med Chile"},{"key":"S1481803519004901_ref3","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.070315"},{"key":"S1481803519004901_ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.15.1889"},{"key":"S1481803519004901_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08657-9"},{"key":"S1481803519004901_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv011"},{"key":"S1481803519004901_ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"S1481803519004901_ref15","doi-asserted-by":"publisher","DOI":"10.1007\/BF02207237"},{"key":"S1481803519004901_ref17","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"key":"S1481803519004901_ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s002239900284"},{"key":"S1481803519004901_ref18","first-page":"700","article-title":"Interpreting estimates of treatment effects: implications for managed care","volume":"33","author":"Faraone","year":"2008","journal-title":"P T"},{"key":"S1481803519004901_ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-016-0765-8"},{"key":"S1481803519004901_ref24","first-page":"73","article-title":"Effect of s-calcitonin on pain related to recent osteoporotic vertebral fractures: a single-blind controlled clinical study against ipriflavone","volume":"14","author":"Lauro","year":"1993","journal-title":"Acta Toxicol Therap"},{"key":"S1481803519004901_ref26","doi-asserted-by":"publisher","DOI":"10.1007\/BF02555844"},{"key":"S1481803519004901_ref31","first-page":"215","article-title":"Effects of a calcitonin treatment on bone pain and resorption parameters due to recent vertebral compression fracture. Results of a double blind and opened study. [French]","volume":"38","author":"Bordier","year":"1986","journal-title":"Rhumatologie"},{"key":"S1481803519004901_ref33","unstructured":"Health Canada. Prescription Drug List. Available at: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/prescription-drug-list\/list.html#a1 (accessed December 27, 2019)."},{"key":"S1481803519004901_ref35","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.131873"},{"key":"S1481803519004901_ref36","unstructured":"Alberta Blue Cross. Alberta Drug Benefit List. Non-Classified Drugs. 2019; 176. Available at: https:\/\/www.ab.bluecross.ca\/dbl\/pdfs\/dbl_all_ptcs.pdf (accessed December 27, 2019)."},{"key":"S1481803519004901_ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3339-z"},{"key":"S1481803519004901_ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1676-0"},{"key":"S1481803519004901_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2004.12.015"},{"key":"S1481803519004901_ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-015-0324-5"},{"key":"S1481803519004901_ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-016-0791-6"}],"container-title":["CJEM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1481803519004901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T23:42:47Z","timestamp":1609458167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1481803519004901\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1481803519004901"],"URL":"https:\/\/doi.org\/10.1017\/cem.2019.490","relation":{},"ISSN":["1481-8035","1481-8043"],"issn-type":[{"value":"1481-8035","type":"print"},{"value":"1481-8043","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,19]]}}}